Semaglutide
Semaglutide is a weight loss (glp-1) peptide. Typical research dosing is once weekly injection, and the body of supporting research is fda approved (ozempic/wegovy).
Buying Semaglutide in the Philippines
- Availability
- Ozempic & Wegovy stocked at Mercury Drug, Watsons, and St. Luke's. Research-grade widely sourced online.
- Price range
- ₱4,500–₱12,000 / pen (Rx) · ₱2,800–₱4,500 / 5mg vial (research)
- Typical pack
- 1mg or 2mg pre-filled pens (Rx) · 5mg lyophilized vials (research)
- Sourcing channel
- Hospital prescription, parallel import, or research peptide supplier
How to source semaglutide in the Philippines
Branded Ozempic and Wegovy are stocked at Mercury Drug, Watsons, and major hospital pharmacies — these require a prescription. Research-grade semaglutide 5mg vials are sourced through peptide suppliers shipping cold-chain to NAIA. Always verify a third-party COA per batch.
What is Semaglutide
Semaglutide is a GLP-1 receptor agonist developed by Novo Nordisk and sold under the brand names Ozempic (diabetes) and Wegovy (obesity). It was the drug that sparked the global weight loss peptide revolution and remains one of the most prescribed medications in the world. For pricing and sourcing in the Philippines specifically, see our 2026 guide.
The STEP clinical trials demonstrated an average weight reduction of 14.9% over 68 weeks at the 2.4mg dose. While this is less than tirzepatide or retatrutide, semaglutide has the longest track record, the most real-world user data, and the most affordable research-grade price point. Browse all weight loss peptide options to compare.
For users new to GLP-1 peptides, or those seeking a reliable, well-understood option, Semaglutide remains an excellent first choice. It is also widely studied for cardiovascular benefits — the SUSTAIN trials showed a 26% reduction in major cardiovascular events.
How it works
Semaglutide activates GLP-1 receptors in the hypothalamus (appetite regulation center of the brain), pancreas (insulin secretion), and gastrointestinal tract (gastric emptying and satiety signaling).
By mimicking the natural GLP-1 hormone (but with a much longer half-life — 7 days vs minutes for natural GLP-1), Semaglutide produces sustained appetite suppression, improved insulin sensitivity, and reduced fasting blood glucose.
The addition of a fatty acid chain to the molecule allows it to bind to albumin in the bloodstream, dramatically extending its half-life and enabling once-weekly dosing.
Semaglutide in the Philippines
Semaglutide is the most reliably-stocked GLP-1 in the country. Branded Ozempic and Wegovy ship to Mercury Drug nationwide on a 2–3 day refill cadence at the high-volume Metro Manila branches — far more consistent than tirzepatide or retatrutide, which still see weeks-long stockouts at most chains.
Most expat buyers in Makati, BGC, and Manila start with a Makati Medical Center or St. Luke's BGC endocrinology consult (PHP 1,500–2,500), then fill the prescription at the in-house pharmacy or any Mercury Drug branch. Research-grade 5mg vials ship same-day via Lalamove cold-chain to Salcedo, Legazpi, BGC, and Rockwell from local suppliers. Cebu and Davao buyers typically use airline-courier with overnight cold packs.
Pricing has compressed in 2026: the prescription pen route runs PHP 14,500–16,500 (USD 260–295) at Makati Med, while research-grade 5mg vials with verified third-party COAs run PHP 2,800–4,500 (USD 50–80). The ~5x gap explains why most self-directed protocols in the country run on research-grade.
Hospitals worth knowing
Makati Medical Center · Makati
Endocrinology bookable in 2–4 days; in-house pharmacy stocks Ozempic and Wegovy
St. Luke's Medical Center BGC · BGC
GLP-1 prescriptions through wellness-medicine clinic; same-day fill possible
The Medical City · Pasig
Endocrinology + diabetes center; Ozempic stocked
Asian Hospital · Alabang
South Metro flagship for endocrinology
Pharmacy stock — what we've seen
Mercury Drug — Glorietta / Greenbelt / Ayala Ave (PSE Tower) · Makati
24–48hr refill on Ozempic; the most reliable retail stock in PH
Mercury Drug — High Street Central / Bonifacio High Street · BGC
Comparable reliability to Makati core
Watson's — Glorietta / Greenbelt · Makati
Reliable second option
What this actually costs in the Philippines
| Item | PHP | USD | Source |
|---|---|---|---|
| Ozempic 1.0mg pen (Rx) | ₱14,500–16,500 | $260–295 | Makati Med in-house pharmacy, May 2026 |
| Ozempic 1.0mg pen (parallel import) | ₱11,800–13,500 | $210–240 | BGC parallel-import outlets |
| Wegovy 2.4mg pen (Rx) | ₱18,000–22,000 | $320–390 | Makati Med, when in stock |
| Research-grade semaglutide 5mg vial | ₱2,800–4,500 | $50–80 | Local supplier with COA, May 2026 |
| Endocrinology consult (specialist) | ₱1,500–2,500 | $27–45 | Makati Med / St. Luke's |
Customs & import reality
Research-grade semaglutide imported as personal-use research material is generally tolerated by the Bureau of Customs (BOC) when shipped in small quantities (under 50 vials) with an invoice describing the material as a research peptide. BOC reserves the right to inspect and detain shipments at NAIA. Do not import for resale — that is a different legal classification entirely.
Reported benefits
- 14.9% average weight reduction in STEP trials (up to 17.4%)
- Proven cardiovascular benefits (26% reduction in major CV events)
- Extensive real-world safety data (7+ years)
- Affordable research-grade price vs Tirzepatide and Retatrutide
- Once-weekly dosing
- Improved blood sugar control
- Available in both injectable and oral forms
Dosing protocol
| Phase | Dose | Frequency | Duration |
|---|---|---|---|
| Starting | 0.25mg | Once weekly | Weeks 1–4 |
| Titration 1 | 0.5mg | Once weekly | Weeks 5–8 |
| Titration 2 | 1mg | Once weekly | Weeks 9–16 |
| Titration 3 | 1.7mg | Once weekly | Weeks 17–20 |
| Maintenance | 2.4mg | Once weekly | Ongoing |
Always start at the lowest effective dose and titrate up gradually.
Side effects
Common
- Nausea (very common in first 4–8 weeks)
- Diarrhea or constipation
- Vomiting (usually subsides after 2–4 weeks)
- Decreased appetite
- Burping or acid reflux
- Injection site redness or swelling
Rare
- Pancreatitis
- Diabetic retinopathy changes (in existing diabetics)
- Gallstones or cholecystitis
- Rapid heart rate
Who should not use Semaglutide
What to expect
Week 1–4 (0.25mg)
Starting dose is sub-therapeutic — mainly for GI tolerance. Some mild nausea. Appetite slightly reduced.
Week 5–8 (0.5mg)
Noticeable appetite reduction begins. Most users lose 2–4kg in this phase. Nausea may increase then settle.
Month 3–6
Consistent weight loss at higher doses. Food cravings significantly reduced. The "food noise" effect is commonly reported.
Month 6+
Weight loss slows. Many users remain at 1mg or 1.7mg as maintenance. Some switch to Tirzepatide for additional results.
FAQ
What is the difference between Ozempic and research Semaglutide?
Should I start with Semaglutide or Tirzepatide?
How long does reconstituted Semaglutide last?
Can I use Semaglutide long-term?
Where to get Semaglutide in the Philippines
For Philippines-specific sourcing routes, hospital availability, pricing breakdowns, and supplier red flags, read the full guide. For the legal status of semaglutide in the Philippines, see the legality guide. Or browse the community-verified supplier list.
Primary sources
Citations supporting the clinical claims on this page. Each entry links to the primary record.
- [01]
STEP 1 Trial — semaglutide 2.4mg for obesity
TrialWilding JPH et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity." N Engl J Med 2021;384:989-1002.
DOI: 10.1056/NEJMoa2032183 - [02]
SUSTAIN-6 — cardiovascular outcomes
TrialMarso SP et al. "Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes." N Engl J Med 2016;375:1834-1844.
DOI: 10.1056/NEJMoa1607141 - [03]
SELECT — CV events in non-diabetic obesity
TrialLincoff AM et al. "Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes." N Engl J Med 2023;389:2221-2232.
DOI: 10.1056/NEJMoa2307563 - [04]
Ozempic Prescribing Information — FDA Label
LabelNovo Nordisk. Ozempic (semaglutide) injection prescribing information. US FDA-approved label.
Source - [05]
GLP-1 receptor agonist mechanism review
MechanismDrucker DJ. "Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1." Cell Metabolism 2018;27(4):740-756.
DOI: 10.1016/j.cmet.2018.03.001
Risk · Disclosure · Editorial Status
This page is editorial information for adults researching peptide therapy. It is not medical advice, not a prescription, and not an endorsement of any specific product, supplier, or protocol. Side effects can be serious and individual response varies. Talk to a licensed physician — ideally one with peptide-specific clinical experience — before starting any compound, adjusting a dose, or discontinuing therapy.
In the Philippines, GLP-1 medications are prescription-only under FDA Philippines regulation. Research-grade peptides occupy a regulatory gray area: import for personal research use is generally tolerated, but the Bureau of Customs reserves the right to inspect and detain shipments. Do not import for resale.
Editorial Status
Independent · Non-clinical
Affiliation
Not a clinic · Not a pharmacy
Last Updated
May 7, 2026